{"input_drugs":["simvastatin","clarithromycin"],"interactions":[{"pair":["simvastatin","clarithromycin"],"has_interaction":true,"max_confidence":0.8,"evidence":[{"pair":["simvastatin","clarithromycin"],"sentence":"DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis ( 2.3 , 2.4 , 4 , 5.1 , 7.1 , 7.2 , 7.3 , 12.3 ) Interacting Agents Prescribing Recommendations Strong CYP3A4 inhibitors (e.g. itraconazole, ketoconazole, posaconazole, voriconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone cobicistat-containing products), gemfibrozil, cyclosporine, danazol Contraindicated with simvastatin Verapamil, diltiazem, dronedarone Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Lomitapide For patients with HoFH, do not exceed 20 mg simvastatin daily For patients with HoFH who have been taking 80 mg simvastatin chronically (e.g., for 12 months or more) without evidence of muscle toxicity, do not exceed 40 mg simvastatin when taking lomitapide.","confidence":0.8,"triggered":true,"class_derived":false,"negated":false,"provenance":{"set_id":"56456210-2db5-4f0d-e054-00144ff8d46c","label_date":"20241226","section_name":"drug_interactions","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=56456210-2db5-4f0d-e054-00144ff8d46c"}},{"pair":["simvastatin","clarithromycin"],"sentence":"If treatment with itraconazole, ketoconazole, posaconazole, voriconazole, erythromycin, clarithromycin or telithromycin is unavoidable, therapy with simvastatin must be suspended during the course of treatment.","confidence":0.5,"triggered":false,"class_derived":false,"negated":false,"provenance":{"set_id":"56456210-2db5-4f0d-e054-00144ff8d46c","label_date":"20241226","section_name":"drug_interactions","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=56456210-2db5-4f0d-e054-00144ff8d46c"}},{"pair":["simvastatin","clarithromycin"],"sentence":"<table ID=\"ID_5FB75B18-994D-4A20-9A3A-419F83595F14\" border=\"grid\" width=\"357.000\"><caption ID=\"ID_55FC3BFF-6845-477F-8B07-307A3FC951D0\"> Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis ( <linkHtml href=\"#dosing3\">2.3</linkHtml>, <linkHtml href=\"#dosing4\">2.4</linkHtml>, <linkHtml href=\"#contraindications\">4</linkHtml>, <linkHtml href=\"#i4i_section_ID_4FD678AF-6EB7-455F-BCB8-E75468F55FF2\">5.1</linkHtml>, <linkHtml href=\"#i4i_section_ID_7E1615A3-A89A-4732-AA79-E6D67B4C43DA\">7.1</linkHtml>, <linkHtml href=\"#i4i_section_ID_179D3C13-C346-4247-B12B-046258E855CA\">7.2</linkHtml>, <linkHtml href=\"#blockers\">7.3</linkHtml>, <linkHtml href=\"#i4i_pharmacokinetics_ID_25B1B3F5-7F81-4DB6-A229-FC827A32BB83\">12.3</linkHtml>) </caption><col width=\"49.3%\"/><col width=\"50.7%\"/><thead><tr ID=\"ID_A71DA351-3876-418C-A6A3-7144CB2F26DE\"><td align=\"center\" valign=\"top\"><content styleCode=\"bold\">Interacting Agents</content></td><td align=\"center\" valign=\"top\"><content styleCode=\"bold\">Prescribing Recommendations</content></td></tr></thead><tbody><tr ID=\"ID_7B3C6CE1-E0E0-457C-B991-57B0FB5DE726\"><td align=\"left\" valign=\"top\"> Strong CYP3A4 inhibitors (e.g. itraconazole, ketoconazole, posaconazole, voriconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone cobicistat-containing products), gemfibrozil, cyclosporine, danazol </td><td align=\"left\" valign=\"top\">Contraindicated with simvastatin</td></tr><tr ID=\"ID_10CBA7CE-B59A-484A-9832-DA2A6A667074\"><td align=\"left\" valign=\"top\">Verapamil, diltiazem, dronedarone</td><td align=\"left\" valign=\"top\">Do not exceed 10 mg simvastatin daily</td></tr><tr><td align=\"left\" valign=\"top\">Amiodarone, amlodipine, ranolazine</td><td align=\"left\" valign=\"top\">Do not exceed 20 mg simvastatin daily</td></tr><tr><td align=\"left\" valign=\"top\">Lomitapide</td><td align=\"left\" valign=\"top\">For patients with HoFH, do not exceed 20 mg simvastatin daily <footnote ID=\"ID-11\">For patients with HoFH who have been taking 80 mg simvastatin chronically (e.g., for 12 months or more) without evidence of muscle toxicity, do not exceed 40 mg simvastatin when taking lomitapide.</footnote></td></tr><tr ID=\"ID_B4F49123-2AE9-47E6-8EF7-9F94B9C22675\"><td align=\"justify\" valign=\"top\">Grapefruit juice</td><td align=\"left\" valign=\"top\">Avoid grapefruit juice </td></tr></tbody></table>","confidence":0.8,"triggered":true,"class_derived":false,"negated":false,"provenance":{"set_id":"56456210-2db5-4f0d-e054-00144ff8d46c","label_date":"20241226","section_name":"drug_interactions_table","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=56456210-2db5-4f0d-e054-00144ff8d46c"}},{"pair":["simvastatin","clarithromycin"],"sentence":"DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis ( 2.3 , 2.4 , 4 , 5.1 , 7.1 , 7.2 , 7.3 , 12.3 ) Interacting Agents Prescribing Recommendations Strong CYP3A4 inhibitors (e.g. itraconazole, ketoconazole, posaconazole, voriconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone cobicistat-containing products), gemfibrozil, cyclosporine, danazol Contraindicated with simvastatin Niacin (≥1 g/day) For Chinese patients, not recommended with simvastatin Verapamil, diltiazem, dronedarone Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Lomitapide For patients with HoFH, do not exceed 20 mg simvastatin daily For patients with HoFH who have been taking 80 mg simvastatin chronically (e.g., for 12 months or more) without evidence of muscle toxicity, do not exceed 40 mg simvastatin when taking lomitapide.","confidence":0.8,"triggered":true,"class_derived":false,"negated":false,"provenance":{"set_id":"8e986df7-3020-6755-e053-2995a90aca37","label_date":"20240618","section_name":"drug_interactions","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8e986df7-3020-6755-e053-2995a90aca37"}},{"pair":["simvastatin","clarithromycin"],"sentence":"<table ID=\"ID_5FB75B18-994D-4A20-9A3A-419F83595F14\" border=\"grid\" width=\"357.000\"><caption ID=\"ID_55FC3BFF-6845-477F-8B07-307A3FC951D0\"> Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis ( <linkHtml href=\"#dosing3\">2.3</linkHtml>, <linkHtml href=\"#dosing4\">2.4</linkHtml>, <linkHtml href=\"#contraindications\">4</linkHtml>, <linkHtml href=\"#i4i_section_ID_4FD678AF-6EB7-455F-BCB8-E75468F55FF2\">5.1</linkHtml>, <linkHtml href=\"#i4i_section_ID_7E1615A3-A89A-4732-AA79-E6D67B4C43DA\">7.1</linkHtml>, <linkHtml href=\"#i4i_section_ID_179D3C13-C346-4247-B12B-046258E855CA\">7.2</linkHtml>, <linkHtml href=\"#blockers\">7.3</linkHtml>, <linkHtml href=\"#i4i_pharmacokinetics_ID_25B1B3F5-7F81-4DB6-A229-FC827A32BB83\">12.3</linkHtml>) </caption><col width=\"49.3%\"/><col width=\"50.7%\"/><thead><tr ID=\"ID_A71DA351-3876-418C-A6A3-7144CB2F26DE\"><td align=\"center\" valign=\"top\"><content styleCode=\"bold\">Interacting Agents</content></td><td align=\"center\" valign=\"top\"><content styleCode=\"bold\">Prescribing Recommendations</content></td></tr></thead><tbody><tr ID=\"ID_7B3C6CE1-E0E0-457C-B991-57B0FB5DE726\"><td align=\"left\" valign=\"top\"> Strong CYP3A4 inhibitors (e.g. itraconazole, ketoconazole, posaconazole, voriconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone cobicistat-containing products), gemfibrozil, cyclosporine, danazol </td><td align=\"left\" valign=\"top\">Contraindicated with simvastatin</td></tr><tr ID=\"ID_10CBA7CE-B59A-484A-9832-DA2A6A667074\"><td align=\"left\" valign=\"top\">Niacin (&#x2265;1 g/day)</td><td align=\"left\" valign=\"top\">For Chinese patients, not recommended with simvastatin</td></tr><tr><td align=\"left\" valign=\"top\">Verapamil, diltiazem, dronedarone</td><td align=\"left\" valign=\"top\">Do not exceed 10 mg simvastatin daily</td></tr><tr><td align=\"left\" valign=\"top\">Amiodarone, amlodipine, ranolazine</td><td align=\"left\" valign=\"top\">Do not exceed 20 mg simvastatin daily</td></tr><tr><td align=\"left\" valign=\"top\">Lomitapide</td><td align=\"left\" valign=\"top\">For patients with HoFH, do not exceed 20 mg simvastatin daily <footnote ID=\"ID-11\">For patients with HoFH who have been taking 80 mg simvastatin chronically (e.g., for 12 months or more) without evidence of muscle toxicity, do not exceed 40 mg simvastatin when taking lomitapide.</footnote></td></tr><tr ID=\"ID_B4F49123-2AE9-47E6-8EF7-9F94B9C22675\"><td align=\"justify\" valign=\"top\">Grapefruit juice</td><td align=\"left\" valign=\"top\">Avoid grapefruit juice </td></tr></tbody></table>","confidence":0.8,"triggered":true,"class_derived":false,"negated":false,"provenance":{"set_id":"8e986df7-3020-6755-e053-2995a90aca37","label_date":"20240618","section_name":"drug_interactions_table","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8e986df7-3020-6755-e053-2995a90aca37"}},{"pair":["simvastatin","clarithromycin"],"sentence":"DRUG INTERACTIONS Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis ( 2.3 , 4 , 5.1 , 7.1 , 7.2 , 7.3 , 12.3 ) Interacting Agents Prescribing Recommendations Strong CYP3A4 inhibitors (e.g. itraconazole, ketoconazole, posaconazole, voriconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol Contraindicated with simvastatin Verapamil, diltiazem, dronedarone Do not exceed 10 mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20 mg simvastatin daily Grapefruit juice Avoid grapefruit juice • Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (≥1 g/day) of niacin increases the risk of adverse skeletal muscle effects.","confidence":0.8,"triggered":true,"class_derived":false,"negated":false,"provenance":{"set_id":"ca760e79-5d8c-4b36-9899-0d37e8e1f24e","label_date":"20220501","section_name":"drug_interactions","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ca760e79-5d8c-4b36-9899-0d37e8e1f24e"}},{"pair":["simvastatin","clarithromycin"],"sentence":"<table width=\"100%\"><caption> Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (<linkHtml href=\"#dosing3\">2.3</linkHtml>, <linkHtml href=\"#contraindications\">4</linkHtml>, <linkHtml href=\"#i4i_section_ID_4FD678AF-6EB7-455F-BCB8-E75468F55FF2\">5.1</linkHtml>, <linkHtml href=\"#i4i_section_ID_7E1615A3-A89A-4732-AA79-E6D67B4C43DA\">7.1</linkHtml>, <linkHtml href=\"#i4i_section_ID_179D3C13-C346-4247-B12B-046258E855CA\">7.2</linkHtml>, <linkHtml href=\"#blockers\">7.3</linkHtml>, <linkHtml href=\"#i4i_pharmacokinetics_ID_25B1B3F5-7F81-4DB6-A229-FC827A32BB83\">12.3</linkHtml>) </caption><col width=\"49%\"/><col width=\"51%\"/><thead><tr><th align=\"center\" styleCode=\"Botrule Toprule \" valign=\"top\"><content styleCode=\"bold\">Interacting Agents</content></th><th align=\"center\" styleCode=\"Botrule Toprule \" valign=\"top\"><content styleCode=\"bold\">Prescribing Recommendations</content></th></tr></thead><tbody><tr><td styleCode=\"Toprule \" valign=\"top\"><list listType=\"ordered\"><item><caption> </caption> Strong CYP3A4 inhibitors (e.g. itraconazole, ketoconazole, posaconazole, voriconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone), gemfibrozil, cyclosporine, danazol </item></list></td><td styleCode=\"Toprule \" valign=\"top\"><paragraph>Contraindicated with simvastatin</paragraph></td></tr><tr><td valign=\"top\"><paragraph>Verapamil, diltiazem, dronedarone</paragraph></td><td valign=\"top\"><paragraph>Do not exceed 10 mg simvastatin daily</paragraph></td></tr><tr><td valign=\"top\"><paragraph>Amiodarone, amlodipine, ranolazine</paragraph></td><td valign=\"top\"><paragraph>Do not exceed 20 mg simvastatin daily</paragraph></td></tr><tr><td styleCode=\"Botrule \" valign=\"top\"><paragraph>Grapefruit juice</paragraph></td><td styleCode=\"Botrule \" valign=\"top\"><paragraph>Avoid grapefruit juice </paragraph></td></tr></tbody></table>","confidence":0.8,"triggered":true,"class_derived":false,"negated":false,"provenance":{"set_id":"ca760e79-5d8c-4b36-9899-0d37e8e1f24e","label_date":"20220501","section_name":"drug_interactions_table","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ca760e79-5d8c-4b36-9899-0d37e8e1f24e"}},{"pair":["simvastatin","clarithromycin"],"sentence":"<table ID=\"ID_5FB75B18-994D-4A20-9A3A-419F83595F14\" border=\"grid\" width=\"357.000\"> <caption ID=\"ID_55FC3BFF-6845-477F-8B07-307A3FC951D0\"> Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis ( <linkHtml href=\"#dosing3\">2.3</linkHtml>, <linkHtml href=\"#dosing4\">2.4</linkHtml>, <linkHtml href=\"#contraindications\">4</linkHtml>, <linkHtml href=\"#i4i_section_ID_4FD678AF-6EB7-455F-BCB8-E75468F55FF2\">5.1</linkHtml>, <linkHtml href=\"#i4i_section_ID_7E1615A3-A89A-4732-AA79-E6D67B4C43DA\">7.1</linkHtml>, <linkHtml href=\"#i4i_section_ID_179D3C13-C346-4247-B12B-046258E855CA\">7.2</linkHtml>, <linkHtml href=\"#blockers\">7.3</linkHtml>, <linkHtml href=\"#i4i_pharmacokinetics_ID_25B1B3F5-7F81-4DB6-A229-FC827A32BB83\">12.3</linkHtml>) </caption> <col width=\"49.3%\"/> <col width=\"50.7%\"/> <thead> <tr ID=\"ID_A71DA351-3876-418C-A6A3-7144CB2F26DE\"> <td align=\"center\" valign=\"top\"> <content styleCode=\"bold\">Interacting Agents</content> </td> <td align=\"center\" valign=\"top\"> <content styleCode=\"bold\">Prescribing Recommendations</content> </td> </tr> </thead> <tbody> <tr ID=\"ID_7B3C6CE1-E0E0-457C-B991-57B0FB5DE726\"> <td align=\"left\" valign=\"top\"> Strong CYP3A4 inhibitors (e.g. itraconazole, ketoconazole, posaconazole, voriconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone cobicistat-containing products), gemfibrozil, cyclosporine, danazol </td> <td align=\"left\" valign=\"top\">Contraindicated with simvastatin</td> </tr> <tr ID=\"ID_10CBA7CE-B59A-484A-9832-DA2A6A667074\"> <td align=\"left\" valign=\"top\">Verapamil, diltiazem, dronedarone</td> <td align=\"left\" valign=\"top\">Do not exceed 10 mg simvastatin daily</td> </tr> <tr> <td align=\"left\" valign=\"top\">Amiodarone, amlodipine, ranolazine</td> <td align=\"left\" valign=\"top\">Do not exceed 20 mg simvastatin daily</td> </tr> <tr> <td align=\"left\" valign=\"top\">Lomitapide</td> <td align=\"left\" valign=\"top\">For patients with HoFH, do not exceed 20 mg simvastatin daily <footnote ID=\"ID-11\">For patients with HoFH who have been taking 80 mg simvastatin chronically (e.g., for 12 months or more) without evidence of muscle toxicity, do not exceed 40 mg simvastatin when taking lomitapide.</footnote> </td> </tr> <tr ID=\"ID_B4F49123-2AE9-47E6-8EF7-9F94B9C22675\"> <td align=\"justify\" valign=\"top\">Grapefruit juice</td> <td align=\"left\" valign=\"top\">Avoid grapefruit juice </td> </tr> </tbody> </table>","confidence":0.8,"triggered":true,"class_derived":false,"negated":false,"provenance":{"set_id":"121b0e00-abb7-4e07-a7b2-311be89fabb7","label_date":"20190325","section_name":"drug_interactions_table","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=121b0e00-abb7-4e07-a7b2-311be89fabb7"}},{"pair":["simvastatin","clarithromycin"],"sentence":"The use of clarithromycin with lomitapide, simvastatin, lovastatin, ergotamine, or dihydroergotamine is contraindicated [see Contraindications ( 4.5 , 4.6 ) and Drug Interactions ( 7 )] .","confidence":0.8,"triggered":true,"class_derived":false,"negated":false,"provenance":{"set_id":"d5be5f12-6392-4d7d-ab23-ebc205ac1a85","label_date":"20250410","section_name":"warnings_and_cautions","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d5be5f12-6392-4d7d-ab23-ebc205ac1a85"}},{"pair":["simvastatin","clarithromycin"],"sentence":"HMG-CoA Reductase Inhibitors (statins): Concomitant use of clarithromycin with lovastatin or simvastatin is contraindicated [see Contraindications ( 4.5 )] as these statins are extensively metabolized by CYP3A4, and concomitant treatment with clarithromycin increases their plasma concentration, which increases the risk of myopathy, including rhabdomyolysis.","confidence":0.8,"triggered":true,"class_derived":false,"negated":false,"provenance":{"set_id":"d5be5f12-6392-4d7d-ab23-ebc205ac1a85","label_date":"20250410","section_name":"warnings_and_cautions","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d5be5f12-6392-4d7d-ab23-ebc205ac1a85"}},{"pair":["simvastatin","clarithromycin"],"sentence":"If treatment with clarithromycin cannot be avoided, therapy with lovastatin or simvastatin must be suspended during the course of treatment.","confidence":0.5,"triggered":false,"class_derived":false,"negated":false,"provenance":{"set_id":"d5be5f12-6392-4d7d-ab23-ebc205ac1a85","label_date":"20250410","section_name":"warnings_and_cautions","url":"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d5be5f12-6392-4d7d-ab23-ebc205ac1a85"}}]}],"metrics":{"requests_total":4.0,"rxnorm_cache_hits":3.0},"sources_checked":{"openfda":{"queries":4,"labels":22,"hits":7},"dailymed":{"queries":0,"labels":0,"hits":0}},"note":null,"version":"1.1.0"}